Aurobindo Ph Sept '08 qtr PAT seen at Rs 286.8 Cr: Religare

Published on Wed, Oct 08, 2008 at 17:22 |  Source : Moneycontrol.com

Updated at Wed, Oct 08, 2008 at 18:33  

18213 Investors following Aurobindo Pharm. Share this News with them.
0
0
Share on Tumblr

ALSO READ

Religare Hichens Harrison Research has come out with its earning estimates on Pharma sector for the quarter ended September 2008. According to the research firm, Aurobindo Pharma's September quarter sales is expected to go up 24.2% at Rs 13,640 million (Rs 1364 crore) on YoY basis.

The company's PAT is seen up 65.2% at Rs 2868 million (Rs 286.8 crore) on YoY basis.

  

More on Moneycontrol

Trending News

Business News

6 ways to backup mobile data
Forget the IIP: there's free cash oozing out of every pore "Forget the IIP: there's free cash oozing out of every pore "

DLF Says Macro Environment Unfavourable W/High Comm & Labour Inflation

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 21:39

Tulsian buys steel stocks; negative on sugar, ADAG

- in MARKET OUTLOOK

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Feb 10 2012, 15:35 | Source: CNBC-TV18

Expect Q4 GRMs to be similar to Q3: BPCL  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com